VCEL Q4 2020 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$45M+14.8% YoY

Gross Profit

$34M74.4% margin

Operating Income

$12M27.2% margin

Net Income

$12M27.0% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+40.2%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$206M

Total Liabilities

$71M

Stockholders' Equity

$134M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$39M	+14.8%
Gross Profit	$34M	$29M	+16.8%
Operating Income	$12M	$9M	+33.4%
Net Income	$12M	$10M	+28.6%